1.
Deprest, J., Ghidini, A., Van Mieghem, T., Bianchi, D.W., Faas, B., Chitty, L.S.: In case you missed it: the  editors bring you the most significant advances of 2015. Prenatal Diagnosis. 36, 3–9 (2016). https://doi.org/10.1002/pd.4758.
2.
Smith, N.C., Smith, A.P.M., Smith, N.C.: Obstetric and gynaecological ultrasound made easy. Elsevier Churchill Livingstone, Edinburgh (2006).
3.
Pandya, P.P., Wapner, R., Oepkes, D., Sebire, N.J. eds: Fetal medicine: basic science and clinical practice. Elsevier, [London?] (2020).
4.
Sadler, T.W.: Langman’s medical embryology. Wolters Kluwer, Philadelphia (2015).
5.
Baillière’s Clinical Obstetrics and Gynaecology. 1, (1987).
6.
Milunsky, A., Milunsky, J.M. eds: Genetic Disorders and the Fetus. John Wiley & Sons Ltd., Oxford, UK (2021). https://doi.org/10.1002/9781119676980.
7.
Simpson, J.L., Elias, S.: Essentials of prenatal diagnosis. Churchill Livingstone, New York (1993).
8.
Harrison, M.R., Golbus, M.S., Filly, R.A., Harrison, M.R.: The unborn patient: the art and science of fetal therapy. Saunders, Philadelphia (2001).
9.
Chudleigh, P., Thilaganathan, B.: Obstetric ultrasound: how, why and when. Elsevier Churchill Livingstone, Edinburgh (2004).
10.
Abramsky, L., Chapple, J.: Prenatal diagnosis: the human side. Nelson Thornes, Cheltenham, U.K. (2003).
11.
International Society for Prenatal Diagnosis: Prenatal diagnosis. Wiley medical publication,.
12.
International Fetal Medicine and Surgery Society: Fetal diagnosis and therapy.
13.
European Society of Human Genetics: European journal of human genetics: EJHG.
14.
Journal of Prenatal Medicine.
15.
PloS one.
16.
American Association for Clinical Chemistry: Clinical chemistry.
17.
Journal of Medical Ethics. (1975).
18.
Massachusetts Medical Society: The New England journal of medicine.
19.
Wald, N.J., Bestwick, J.P.: Performance of antenatal reflex DNA screening for Down’s syndrome. Journal of Medical Screening. 22, 168–174 (2015). https://doi.org/10.1177/0969141315581005.
20.
nipd_june_2016.pdf, http://www.labs.gosh.nhs.uk/media/764057/nipd_june_2016.pdf.
21.
Chitty, L.S., van der Schoot, C.E., Hahn, S., Avent, N.D.: SAFE—TheSpecial Non-invasiveAdvances inFetal and NeonatalEvaluation Network: aims and achievements. Prenatal Diagnosis. 28, 83–88 (2008). https://doi.org/10.1002/pd.1929.
22.
Wright, C.F., Burton, H.: The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis. Human Reproduction Update. 15, 139–151 (2008). https://doi.org/10.1093/humupd/dmn047.
23.
Hill, M., Barrett, A.N., White, H., Chitty, L.S.: Uses of cell free fetal DNA in maternal circulation. Best Practice & Research Clinical Obstetrics & Gynaecology. 26, 639–654 (2012). https://doi.org/10.1016/j.bpobgyn.2012.03.004.
24.
Sparks, A.B., Wang, E.T., Struble, C.A., Et al.: Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenatal Diagnosis. 32, 3–9 (2012). https://doi.org/10.1002/pd.2922.
25.
Barrett, A.N., McDonnell, T.C.R., Chan, K.C.A., Chitty, L.S.: Digital PCR Analysis of Maternal Plasma for Noninvasive Detection of Sickle Cell Anemia. Clinical Chemistry. 58, 1026–1032 (2012). https://doi.org/10.1373/clinchem.2011.178939.
26.
Bianchi, D.W., Platt, L.D., Goldberg, J.D., Et al.: Genome-Wide Fetal Aneuploidy Detection by Maternal Plasma DNA Sequencing. Obstetrics & Gynecology. 119, 890–901 (2012).
27.
Ravitsky, V.: Non-invasive prenatal diagnosis: an ethical imperative. Nature Reviews Genetics. 10, 733–733 (2009). https://doi.org/10.1038/nrg2631-c1.
28.
Benn, P.A.: Practical and Ethical Considerations of Noninvasive Prenatal Diagnosis. JAMA. 301, (2009). https://doi.org/10.1001/jama.2009.707.
29.
Deans, Z., Clarke, A.J., Newson, A.J.: For Your Interest? The Ethical Acceptability of Using Non-Invasive Prenatal Testing to Test ‘Purely for Information’. Bioethics. 29, 19–25 (2015). https://doi.org/10.1111/bioe.12125.
30.
Agathokleous, M., Chaveeva, P., Poon, L.C.Y., Et al.: Meta-analysis of second-trimester markers for trisomy 21. Ultrasound in Obstetrics & Gynecology. 41, 247–261 (2013). https://doi.org/10.1002/uog.12364.
31.
Celik, E., To, M., Poon, L.C.Y., Et al.: Cervical length and obstetric history predict spontaneous preterm birth: development and validation of a model to provide individualized risk assessment. Ultrasound in Obstetrics and Gynecology. 31, 549–554 (2008). https://doi.org/10.1002/uog.5333.
32.
Gallo, D., Poon, L.C., Fernandez, M., Et al.: Prediction of Preeclampsia by Mean Arterial Pressure at 11-13 and 20-24 Weeks’ Gestation. Fetal Diagnosis and Therapy. 36, 28–37 (2014). https://doi.org/10.1159/000360287.
33.
Gallo, D.M., Poon, L.C., Akolekar, R., Et al.: Prediction of Preeclampsia by Uterine Artery Doppler at 20-24 Weeks’ Gestation. Fetal Diagnosis and Therapy. 34, 241–247 (2013). https://doi.org/10.1159/000356171.
34.
Nicolaides, K.H.: Turning the Pyramid of Prenatal Care. Fetal Diagnosis and Therapy. 29, 183–196 (2011). https://doi.org/10.1159/000324320.
35.
Syngelaki, A., Chelemen, T., Dagklis, T., Et al.: Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11-13 weeks. Prenatal Diagnosis. 31, 90–102 (2011). https://doi.org/10.1002/pd.2642.
36.
Syngelaki, A., Pergament, E., Homfray, T., Et al.: Replacing the Combined Test by Cell-Free DNA Testing in Screening for Trisomies 21, 18 and 13: Impact on the Diagnosis of Other Chromosomal Abnormalities. Fetal Diagnosis and Therapy. 35, 174–184 (2014). https://doi.org/10.1159/000358388.
37.
Alessandra Cacciatore: Obstetric management in Rh alloimmunizated pregnancy. Journal of Prenatal Medicine. 3, (2009).